Sub menu

 

 

Grifols Australia Pty Ltd

Regulatory activities for this sponsor.

Type

Date

Filters applied:Clear all
13 result(s) found, displaying 11 to 13

  • Xembify

    Prescription medicine decision summary
    TGA decision: Xembify (normal immunoglobulin human) is approved to treat primary immunodeficiency diseases (PID).

  • AusPAR: VeraSeal

    Australian public assessment report (AusPar)
    VeraSeal (human fibrinogen and human thrombin) for the supportive treatment of hemostasis.